Supplements and Featured Publications

The Burden of the Rare Kidney Disorder Focal Segmental Glomerulosclerosis (FSGS)

Exclusive Coverage of the European Respiratory Society Congress 2026
Coverage of the European Respiratory Society Congress 2026, September 5-9, 2026, Barcelona, Spain.

Continuous Glucose Monitoring for Adults With Type 2 Diabetes Not Treated With Insulin: Evidence to Inform Managed Care Coverage and Access Decisions

Improving Access and Reducing Burden in Automated Insulin Delivery: The Impact of a Fully Disposable Tubeless Form Factor

Self-Administered Treatment in Paroxysmal Supraventricular Tachycardia (PSVT): Clinical and Payer Considerations With CARDAMYST® (Etripamil)

Coverage, Access, and Managed Care Decision-Making: Evidence for Exon-Skipping Therapies in Duchenne Muscular Dystrophy

The JAK Inhibitor Shift in Vitiligo: A Critical Review of Clinical Data and Economic Realities

Evolving Approaches in HER2-Mutant Non–Small Cell Lung Cancer: Emerging Evidence and Practical Considerations

Unlocking Access: Operationalizing CAR T-Cell Therapy in the Community

Moderate to Severe Atopic Dermatitis Care in Practice: Disease Burden and Integrated Care Pathways

The Tissue Systems Pathology Test Predicts Risk of Progression to High-Grade Dysplasia or Esophageal Adenocarcinoma for Patients With Non-Dysplastic Barrett's Esophagus

Clinical and Economic Value of Tralokinumab (ADBRY®) for Patients With Moderate to Severe Atopic Dermatitis

Considerations for the Management of Overactive Bladder in Long-Term Care

TONMYA® (cyclobenzaprine HCl sublingual tablets): An Innovative Approach to Fibromyalgia Management

Exclusive Coverage of the American Thoracic Society 2026 International Conference
Coverage of the American Thoracic Society 2026 International Conference, May 15-20, 2026, in Orlando, Florida

From Academic Centers to Community Practice: The Next Chapter in CAR T-Cell Therapy

Enhancing Chronic Kidney Disease Treatment With Guideline-Directed Medical Therapies Through Electronic Alert Systems and Integrated Care Management Initiatives

Clinical and Economic Value of ENTYVIO® (vedolizumab): Implications for Ulcerative Colitis and Crohn Disease Management

Alopecia Areata: Clinical Evidence and Managed Care Insights for FDA-Approved JAK Inhibitors

Hyperkalemia and Its Treatment: Real-World Evidence and Managed Care Considerations Supporting Use of Potassium Binders

Long-Term Real-World Economic and Clinical Outcomes of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Cystic Fibrosis

Myelofibrosis Treatment: Health Economic Considerations

Continuous Glucose Monitoring at Hospital Discharge: Evidence, Implementation, and Value for Health Systems

Clinical Management and Economic Drivers of Heart Failure With Preserved or Mildly Reduced Ejection Fraction

Exclusive Coverage of the International Stroke Conference 2026
Coverage of the International Stroke Conference 2026, February 4-6, 2026, New Orleans, Louisiana.

Exclusive Coverage of the Conference on Retroviruses and Opportunistic Infections 2026
Coverage of the Conference on Retroviruses and Opportunistic Infections, February 22-25, 2026, Denver, Colorado.

Lambert–Eaton Myasthenic Syndrome: Early Recognition, Diagnostic Precision, and Therapeutic Advances in Small Cell Lung Cancer

A Novel, Double-stranded Small Interfering RNA Therapeutic Designed to Silence Apolipoprotein C-III in Familial Chylomicronemia Syndrome

The Economic Value of Ozempic® (Semaglutide) Injection 0.5 mg, 1 mg, or 2 mg in Medicare Beneficiaries

Exploring Novel Management Options for Alopecia Areata
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Giredestrant Regimen for ESR1-Mutated Breast Cancer
2
Hepatitis B Screening Gaps Persist as Functional Cure Option Arrives
3
IgA Nephropathy, FSGS Care Needs Coordinators, Not Just New Drugs
4
Complicated UTI Care Strained by Unclear Goals, Access Gaps
5
